CheckMyRecalls

Foundation Medicine, Inc. recalls Sequencing Agent SEQ0067

Published
29 Apr 2026
Units affected
163 units
Agency
FDA
Country
United States

The hazard

Possible increase in phasing, potentially resulting in false-positive BARD1 splice site indel artifact variants

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Contact your doctor, clinic or the device maker to find out if your device is affected and what to do next. Do not stop using a life-supporting device without medical advice.

  • Check the model and lot or serial number on the device label.
  • Speak to your doctor or the clinic that supplied the device before stopping use.
Read the official FDA notice

Product details

Sequencing Agent SEQ0067, component of FoundationOne CDx (F1CDx)

Brand / company
Foundation Medicine, Inc.
Codes / lots
Model Number: SEQ0067. Lot Numbers: 24346, 24386, 24488.
Distribution
US Nationwide distribution in the states of Massachusetts and North Carolina.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 29 Apr 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.